对于角膜内皮去补偿的新兴治疗方法 - - 一个系统性审查
Noel Cheong1, Siu Wa Chui1, Stephanie Hiu Ling Poon1
1Department of Ophthalmology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong SAR, China.
概括
新的外科选择,如仅Descemet剥离 (DSO) 和基于细胞的疗法,对角膜内皮脱补偿 (CED) 显示出希望,可能与内皮角膜成形 (EK) 结果相匹配.
科学领域:
- 眼科医生 眼科 眼科
- 再生医学是一种再生医学.
背景情况:
- 角膜内皮失补偿 (CED) 影响视力敏度.
- 内皮角膜整形 (EK) 是标准的,但面临着移植缺口.
- 需要新的治疗方法来解决EK的局限性.
结论:
- DSO和基于细胞的疗法是治疗CED的有希望的策略.
- 需要进一步的大规模,长期的临床试验.
- DSO的简单性和基于细胞的治疗的翻译潜力是其关键优势.
更多相关视频
相关概念视频
01:28Angle Closure Glaucoma: Treatment
578
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
578
01:27Open Angle Glaucoma: Treatment
491
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
491